Supplements for Insulin Resistance: What Works?

Supplements to reverse insulin resistance are widely marketed, but the evidence behind them is more nuanced than many claims suggest. Insulin resistance, where cells respond less effectively to insulin, underlies prediabetes and type 2 diabetes, and addressing it early matters. Certain supplements, including berberine, magnesium and myo-inositol, have shown modest benefits in clinical trials, but none replaces lifestyle change or medical treatment. This article examines what the evidence actually shows, which supplements are best studied, how they interact with NHS guidance, and when to see your GP.

Can supplements actually reverse insulin resistance?

No supplement has been proven to fully reverse insulin resistance; some may modestly improve insulin sensitivity, but effect sizes are smaller than those achieved through diet and exercise. UK food supplements are not assessed by the MHRA for efficacy.

No supplement has been proven to fully reverse insulin resistance, though some may modestly improve insulin sensitivity as part of a broader lifestyle approach. Insulin resistance occurs when cells in the muscles, liver and fat tissue respond less effectively to insulin, causing the pancreas to produce more of the hormone to maintain normal blood glucose levels.^[1] Over time, this can progress to prediabetes and type 2 diabetes if left unaddressed.

The term 'reverse' is often used loosely in popular health content, but clinically, what is achievable is an improvement in insulin sensitivity, meaning cells respond more readily to insulin. This is measurable through markers such as fasting glucose and HbA1c, which are the standard measures used in NHS primary care. HOMA-IR (a calculated estimate of insulin resistance derived from fasting glucose and insulin levels) is also used in research settings, though it is primarily an epidemiological and research index rather than a routine NHS diagnostic tool. Some supplements have shown statistically significant effects on these markers in clinical trials, but effect sizes are generally modest compared with those achieved through dietary change and physical activity.

It is important to approach supplement claims critically. Many studies are small, short in duration, or funded by manufacturers, which can inflate apparent benefits. In the UK, food supplements are regulated under UK food law, overseen by the Food Standards Agency (FSA) and local enforcement authorities. Unlike licensed medicines, they are not assessed by the MHRA for efficacy, and quality and dosing can vary considerably between products. Anyone considering supplements for insulin resistance should discuss this with their GP or a registered dietitian, particularly if they are already taking medication for blood glucose management.

Which supplements have the strongest evidence for insulin sensitivity?

Berberine, magnesium, myo-inositol, alpha-lipoic acid and chromium have the most consistent clinical trial evidence, though all show modest effects and none should replace medical treatment.

Among the supplements studied for insulin sensitivity, berberine, magnesium, inositol (particularly myo-inositol), alpha-lipoic acid and chromium have the most consistent, if still limited, evidence from clinical trials. Each works through a different proposed mechanism, and none should be considered a substitute for medical treatment. Quality and standardisation vary between brands, so choosing a reputable supplier is important.

Berberine is a plant-derived compound that is thought to activate AMP-activated protein kinase (AMPK), an enzyme involved in glucose uptake and metabolism.^[2][3] Several meta-analyses have found it can reduce fasting blood glucose and HbA1c. Some small trials have reported effects in a similar range to metformin, but these comparisons come from studies with significant methodological limitations, including small sample sizes, short duration and heterogeneous populations. Larger, high-quality head-to-head trials are lacking, and this comparison should be interpreted with caution.

Magnesium plays a role in insulin receptor signalling. Low magnesium levels are associated with insulin resistance, and supplementation in people who are deficient has shown improvements in fasting glucose and insulin sensitivity in some trials.^[5][6] Benefit appears greatest in those with confirmed deficiency.

Myo-inositol is particularly studied in polycystic ovary syndrome (PCOS), where insulin resistance is common. It appears to improve insulin signalling and has a reasonable evidence base in this specific population, though evidence in other groups is more limited.

Alpha-lipoic acid is an antioxidant that may improve glucose uptake in muscle cells and reduce oxidative stress, which is thought to contribute to insulin resistance. The proposed mechanisms come largely from preclinical and early clinical data.

Chromium is involved in insulin receptor activity, and supplementation has shown modest reductions in fasting glucose in some trials, though results are inconsistent across studies.

For people exploring these options, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate treatment options may be discussed alongside lifestyle guidance.

How do lifestyle changes work alongside supplements?

Dietary modification and regular physical activity are the most effective interventions for insulin sensitivity; supplements may add modest incremental benefit but are unlikely to produce meaningful results in isolation.

Lifestyle changes, particularly dietary modification and regular physical activity, remain the most effective and evidence-based interventions for improving insulin sensitivity, and supplements are most likely to be beneficial when used alongside these rather than instead of them. NICE guidance on type 2 diabetes prevention (PH38) and the NHS Diabetes Prevention Programme both emphasise structured lifestyle intervention as the primary approach for people with prediabetes or raised insulin resistance.

Diet has a direct effect on insulin sensitivity. Reducing refined carbohydrates and ultra-processed foods, increasing dietary fibre, and following patterns such as a Mediterranean-style diet have all been associated with improved insulin markers in clinical studies. These dietary changes reduce the glycaemic load placed on the pancreas and improve the cellular environment in which insulin acts.

Physical activity increases glucose uptake in muscle cells independently of insulin, through GLUT4 transporter activation.^[11] Both aerobic exercise and resistance training have been shown to improve insulin sensitivity, with effects visible after a single session and sustained with regular practice. UK Chief Medical Officers' guidelines, reflected in NHS guidance, recommend at least 150 minutes of moderate-intensity activity per week for adults, alongside muscle-strengthening activities on two or more days per week.^[12][13]

Sleep and stress management are increasingly recognised as relevant. Chronic sleep deprivation and elevated cortisol from psychological stress both impair insulin signalling. Addressing these factors may enhance the benefit of both lifestyle changes and any supplements being used.

Supplements such as berberine or magnesium may add a modest incremental benefit on top of these changes, but they are unlikely to produce meaningful results in isolation. The combination approach is where the evidence is most plausible.

Are these supplements safe, and what side effects should you watch for?

Most are well tolerated at recommended doses, but berberine and alpha-lipoic acid can increase hypoglycaemia risk when combined with glucose-lowering medicines, and high-dose magnesium is unsafe in kidney disease.

Most supplements studied for insulin sensitivity are generally well tolerated at recommended doses, but they are not without risk, and interactions with prescribed medicines are an important consideration. Because food supplements are regulated under UK food law rather than as medicines, quality control between brands can vary, and the stated dose may not reflect the actual content. Choosing products from reputable suppliers and avoiding excessive doses is advisable.

Berberine commonly causes gastrointestinal side effects including nausea, diarrhoea, constipation and abdominal discomfort, particularly at higher doses. It can interact with metformin and other glucose-lowering medicines, potentially increasing the risk of hypoglycaemia. It should not be used in pregnancy or breastfeeding.

Magnesium supplements at high doses can cause diarrhoea and, in people with kidney disease, may accumulate to harmful levels. People with impaired renal function should seek medical advice before supplementing.

Myo-inositol is generally well tolerated, with mild gastrointestinal effects reported at higher doses. It is considered relatively safe but should be discussed with a clinician if used alongside hormonal treatments.

Alpha-lipoic acid may lower blood glucose and, in combination with diabetes medication, could increase hypoglycaemia risk. Some case reports and small studies have suggested possible effects on thyroid hormone levels, though the evidence is limited and inconsistent; people taking thyroid medication should seek advice from their GP before using it.

Chromium at supplemental doses is generally considered safe, but case reports have raised concerns about kidney and liver effects at very high intakes.^[23][24] Supplemental doses should not substantially exceed recommended amounts.

Several of these supplements may also affect the absorption or metabolism of other medicines, including some antibiotics and levothyroxine. If you take any prescribed medication, speak to your GP or pharmacist before starting a supplement.

If you experience an unexpected reaction to any supplement, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Anyone taking prescribed medication for blood glucose, blood pressure or thyroid conditions should speak to their GP before starting any of these supplements.

What does the NHS say about managing insulin resistance?

The NHS does not recommend supplements for insulin resistance; NICE guidance prioritises structured lifestyle intervention, and where needed, metformin or licensed medicines such as tirzepatide.

The NHS does not recommend supplements as a primary treatment for insulin resistance, and current NICE guidance focuses on structured lifestyle intervention, monitoring and, where appropriate, pharmacological treatment for those who meet clinical criteria. NICE guideline PH38 (preventing type 2 diabetes) and NG28 (type 2 diabetes in adults) both prioritise dietary change, physical activity and weight management as first-line approaches.^[16][17]

For people identified as having prediabetes or being at high risk of type 2 diabetes, the NHS Diabetes Prevention Programme (NHS DPP) offers a structured, evidence-based group programme covering diet, physical activity and behaviour change. Referral is typically made by a GP or practice nurse following a blood test showing raised HbA1c (in the range of 42 to 47 mmol/mol) or impaired fasting glucose.^[16][17]

Where lifestyle measures are insufficient, NICE recommends considering metformin for adults with prediabetes who are at high risk of progression, particularly those who are obese or have other risk factors.^[17][19] For people with established type 2 diabetes and significant obesity, NICE technology appraisals have recommended certain licensed medicines, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists such as tirzepatide (Mounjaro), which is authorised by the MHRA for both type 2 diabetes and chronic weight management.^[20][21] Local Integrated Care Boards (ICBs) make commissioning decisions about which treatments are available within their area.

The NHS does not fund supplements for insulin resistance, and there is no NICE guidance recommending them. Their use remains a personal choice, best made in discussion with a clinician.

When should you speak to a GP instead of trying supplements?

See your GP if you have raised HbA1c, symptoms suggesting high blood glucose, PCOS, or take prescribed medication, as supplements do not replace diagnosis and may interact with treatment.

You should speak to your GP rather than self-managing with supplements if you have symptoms that may indicate significantly raised blood glucose or an underlying condition requiring diagnosis and treatment. Insulin resistance is not always symptomatic, but when it is, signs can include persistent fatigue, increased thirst, frequent urination, difficulty losing weight, skin changes such as acanthosis nigricans (darkening of skin folds), or irregular periods in women. Additional symptoms that may suggest raised blood glucose and warrant prompt assessment include recurrent infections, blurred vision and unintentional weight loss.

A GP appointment is particularly important in the following situations:

• You have a family history of type 2 diabetes or cardiovascular disease and have not had a recent blood glucose check

• You have been told your HbA1c or fasting glucose is raised and have not yet received structured advice

• You have PCOS, non-alcoholic fatty liver disease, or another condition associated with insulin resistance

• You are taking prescribed medication for blood glucose, blood pressure or cholesterol, as supplements may interact with these

• You are pregnant or planning a pregnancy, as blood glucose management is particularly important during this period

• You have tried lifestyle changes for three to six months without improvement in symptoms or blood markers

Supplements are not a substitute for diagnosis. Insulin resistance is a clinical finding identified through blood tests interpreted by a qualified clinician, and supplements should not delay medical assessment. If you develop sudden symptoms such as extreme thirst, confusion or vomiting, contact NHS 111 for urgent advice, or call 999 if you feel seriously unwell. For routine concerns, your GP practice is the appropriate first point of contact.

Scientific References

1. Metabolic syndrome.
2. Berberine, a natural plant product, activates AMP-activated protein kinase (AMPK).
3. Berberine enhances the AMPK activation and autophagy.
4. Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers. Frontiers in Nutrition.
5. Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis. Nutrients.
6. Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial. Frontiers in Nutrition.
7. Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials. BMC Endocrine Disorders.
8. Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis. Frontiers in Endocrinology.
9. Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Clinical Endocrinology.
10. Effects of inositol in women with polycystic ovary syndrome: an umbrella review of meta-analyses from randomized controlled trials. Frontiers in Endocrinology.
11. Exercise, GLUT4, and skeletal muscle glucose uptake.
12. Physical activity guidelines: UK Chief Medical Officers' report.
13. UK Chief Medical Officers' physical activity guidelines (full guidance text).
14. Physical activity guidelines for adults aged 19 to 64.
15. Nutrition legislation information sheet.
16. Type 2 diabetes: prevention in people at high risk (PH38).
17. Type 2 diabetes: prevention in people at high risk — Recommendations (PH38).
18. Type 2 diabetes in adults: management (NG28).
19. Type 2 diabetes in adults: management — Initial medicines (NG28).
20. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
21. Tirzepatide.
22. Tirzepatide: a medicine to manage type 2 diabetes and obesity.
23. Chromium picolinate toxicity. Cerulli J et al..
24. Chromium: toxicological overview.

Frequently Asked Questions